B·R·A·H·M·S PAPP-A KRYPTOR

Outstanding precision: UK NEQAS data 2003-2017 proof mean CV of 3.1%
Kinetic reading – leading to automatic rediluting of high samples within 4 min
In routine use by FMF since 1999

Clinical indication

B·R·A·H·M·S PAPP-A KRYPTOR assay is indicated to be used in conjunction with additional clinical data as an aid in assessing the risk of fetal trisomy 21, 18 and 13, and the risk for developing pre-eclampsia in first trimester screening of pregnant women.

Ease of handling

Sample volume	50 µL
Sample type	Serum
Incubation time	19 min
Direct measuring range	0.004 to 6 IU/L
Measuring range	0.004 to 90 IU/L
Detection limit	0.004 IU/L
Kit stability on board	29 days
Calibrator	1 point
Calibration stability	15 days

Excellent precision

Our B·R·A·H·M·S PAPP-A KRYPTOR assay offers highly precise measurements and a consistent and excellent long-term performance, therefore making KRYPTOR platform the instrument of choice in first trimester screening.

Instruments

B·R·A·H·M·S PAPP-A KRYPTOR is available on:

B·R·A·H·M·S KRYPTOR
B·R·A·H·M·S KRYPTOR compact
B·R·A·H·M·S KRYPTOR compact PLUS

Kit and accessories

Article number	Description
866.075	B·R·A·H·M·S PAPP-A KRYPTOR Kit, reagents for 75 determinations
86691	B·R·A·H·M·S PAPP-A KRYPTOR CAL Calibrator kit, 6 vials
88192	B·R·A·H·M·S GM KRYPTOR QC Control kit prenatal screening, 3 levels (2 vials per level)